654 Results

People

  1. Motzer
    Motzer
  2. Mulhall
    Mulhall
  3. Saltz
    Saltz
  4. Hudis
    Hudis
  5. Abou-Alfa
    Abou-Alfa
  6. Lichtman
    Lichtman
  7. De Angelis
    De Angelis
  8. Ginsberg
    Ginsberg
  9. Russo
    Russo
  10. Feldman
    Feldman

Groups

  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)
  7. Division of Subspecialty Medicine (78)
  8. Center for Hematologic Malignancies (77)
  9. Epidemiology and Biostatistics (69)
  10. Radiology, Department of (61)
  1. "hypertension"
Formats
  1. Journal Article (607)
  2. Review (31)
  3. Editorial (6)
  4. Guidelines (4)
  5. Research Letter (3)
  6. Book Section (1)
  7. Conference Paper (1)
  8. Correspondence (1)
Groups
  1. Department of Medicine (397)
  2. Solid Tumor Oncology Division (270)
  3. Hematologic Malignancies, Division of (99)
  4. Genitourinary Oncology Service (98)
  5. Survivorship Research (97)
  6. Surgery (84)

More Groups

People
  1. Robert Motzer (59)
  2. John Mulhall (21)
  3. Leonard Saltz (18)
  4. Clifford Hudis (16)
  5. Richard Steingart (14)
  6. Ghassan Abou-Alfa (13)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (31)
  4. 2022 (29)
  5. 2021 (23)
  6. 2020 (38)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. Clinical Cancer Research (20)
  3. Lancet Oncology (20)
  4. Cancer (15)
  5. Journal of the National Comprehensive Cancer Network (15)
  6. Journal of Sexual Medicine (14)

More Publications

Publishers
  1. Elsevier Inc. (124)
  2. Elsevier Science, Inc. (58)
  3. Springer (47)
  4. American Society of Clinical Oncology (42)
  5. Oxford University Press (39)
  6. Wiley Blackwell (35)

More Publishers

Results (654)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: Phase 1 study final results
    Journal Article

    Cortes, J. E.; Lang, F.; Rea, D.; Hochhaus, A.; Breccia, M.; Goh, Y. T.; Heinrich, M. C.; Hughes, T. P.; Janssen, J. J. W. M.; le Coutre, P.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results: CHRONIC MYELOID LEUKEMIA
    Journal Article

    Hochhaus, A.; Kim, D. W.; Cortes, J. E.; Sasaki, K.; Mauro, M. J.; Hughes, T. P.; Breccia, M.; Talpaz, M.; Minami, H.; Goh, Y. T.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Oncoral follow-up for outpatients treated with oral anticancer drugs assessed by relative dose intensity
    Journal Article

    Larbre, V.; Ranchon, F.; Maucort-Boulch, D.; Coz, E.; Herledan, C.; Caffin, A. G.; Baudouin, A.; Maire, M.; Romain-Scelle, N.; Vacheron, C. H.; more...
    Pharmaceuticals (2025)

    Fulltext@MSK | Save
  • Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies
    Journal Article

    Ailawadhi, S.; Biru, Y.; Clavreul, S.; Miguel, M. S.; Cormier, N.; Efebera, Y.; Merz, M.; Sato, A.; Zeanah, C.; Watkins, J. L.; more...
    Patient Preference and Adherence (2025)

    Fulltext@MSK | Save
  • Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: A first-in-human, single-centre, phase 1 trial
    Journal Article

    Lou, E.; Choudhry, M. S.; Starr, T. K.; Folsom, T. D.; Bell, J.; Rathmann, B.; DeFeo, A. P.; Kim, J.; Slipek, N.; Jin, Z.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies
    Research Letter

    Bewersdorf, J. P.; Mi, X.; Lu, B.; Kuykendall, A.; Sallman, D.; Patel, M.; Stevens, D.; Philipovskiy, A.; Sutamtewagul, G.; Masarova, L.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: Analysis of key subgroups of the MAIA study
    Journal Article

    Moreau, P.; Facon, T.; Usmani, S. Z.; Bahlis, N.; Raje, N.; Plesner, T.; Orlowski, R. Z.; Basu, S.; Nahi, H.; Hulin, C.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Structural racism and breast cancer stage at presentation in a South Florida majority-minority population: A retrospective study
    Journal Article

    Hernandez, A. E.; Lubarsky, M.; Westrick, A. C.; Cohen, B. L.; Thompson, C.; Kesmodel, S. B.; Goel, N.
    The Lancet Regional Health - Americas (2025)

    Fulltext@MSK | Save
  • (90)Y-Transarterial radioembolization combined with immune checkpoint inhibitors in hepatocellular carcinoma: A systematic review
    Review

    Hosseini Shabanan, S.; Shobeiri, P.; Behnoush, A. H.; Haghshomar, M.; Fowler, K. J.; Lewandowski, R. J.
    Journal of Gastrointestinal Cancer (2025)

    Fulltext@MSK | Save
  • SWOG S1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers
    Journal Article

    Shroff, R. T.; King, G.; Colby, S.; Scott, A. J.; Borad, M. J.; Goff, L.; Matin, K.; Mahipal, A.; Kalyan, A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save